McKesson Corporation has announced that it has launched a new venture capital fund specifically for healthcare start-ups. McKesson plans to invest “several hundred million” dollars into early-stage and growth-stage start-ups.
According to McKesson, “The fund will target companies that are both enabling and benefitting from the disruptive changes affecting the industry. These changes include increasing consumerism, emergence of alternate delivery models, and the shift toward value-based reimbursement models.”
McKesson continued saying that it is looking to make minority investments in places where McKesson doesn’t take part in currently. The company listed four specifics:
- Technology that enables direct-to-consumer health products and services,
- Alternative health care delivery models that help people access care and improve outcomes, quality, and costs,
- Technology that helps employers control workers’ health care costs by changing behaviors and reducing doctor and hospital visits
- Startups working to build health data pipes, workflow systems, and analytics platforms.
McKesson will invest just as any other venture capital firm would – looking for high returns and high involvement from the early stages of the company it has invested in.